Is Chewy a Buy After Its Latest Earnings Report?

Chewy shares fell 11% after Q2 revenue rose 7.3% to $3.33 billion, narrowly exceeding the $3.32 billion consensus, while adjusted EPS of $0.36 matched expectations. Organic revenue growth was only 5.7% excluding SmartPak and Modern Animal, and management flagged continued weakness in discretionary product attachment and premiumization. Chewy raised full-year revenue guidance to $13.46 billion-$13.57 billion and adjusted EBITDA margin guidance to 6.7%-6.8%, but the increase was driven primarily by acquisitions rather than an acceleration in its core business.

Analysis

The key valuation issue is not the quarterly miss-versus-meet framing but the composition of growth: acquisition-led guidance support does little to restore confidence in Chewy's standalone customer-wallet expansion. With autoship penetration already high, incremental revenue is increasingly recurring but lower in optional basket content, limiting both revenue upside and operating leverage. The market is likely to re-rate CHWY toward a mature specialty retailer multiple unless organic growth re-accelerates above roughly 7-8%.

Margin resilience is less protective than it appears. If consumer trading-down persists, the mix can shift from premium food, treats and accessories toward lower-margin replenishment; this would pressure gross margin even if reported revenue remains stable. Competitors with physical-store service ecosystems, notably Petco (WOOF), may be similarly exposed in discretionary categories, while mass merchants Walmart (WMT), Target (TGT), Costco (COST) and Amazon retain the ability to use pet consumables as traffic-driving loss leaders.

The acquisitions create a potentially underappreciated medium-term option: veterinary and specialty-equine exposure can increase customer lifetime value and reduce pure e-commerce commoditization. But the relevant proof point over the next 1-3 quarters is whether acquired businesses generate cross-sell and retention benefits rather than merely purchased growth. A sustained gross-margin decline, weaker active-customer trends, or another guidance raise driven principally by M&A would falsify a constructive thesis.

Consensus may overstate the apparent cheapness by emphasizing adjusted earnings while excluding meaningful equity compensation. On a GAAP earnings basis, CHWY is not clearly discounted relative to its slowing organic growth profile, leaving downside if analysts reset estimates after the next evidence of weak discretionary attachment. Conversely, the post-earnings selloff could be overdone only if management demonstrates stabilization in non-autoship spend during the holiday period; that would support multiple expansion before full-year results.

Key Decisions for Investors

• Maintain an underweight/short bias in CHWY for the next 1-3 months; use a rebound toward the pre-earnings trading range to initiate rather than chase the initial decline. Target a further 10-15% downside if organic growth remains sub-6% at the next report; cover on evidence of accelerating active-customer growth and premium-category recovery.
• Express sector weakness as long WMT or COST / short CHWY over 3-6 months. The pair isolates a likely share shift toward lower-price, omnichannel pet purchasing while retaining exposure to resilient consumables; reassess if CHWY reports sequential gross-margin expansion alongside organic growth above 7%.
• Do not treat the forward adjusted P/E as a standalone long signal. Set an alert for a valuation reset nearer a low-teens GAAP P/E equivalent, combined with independently disclosed acquisition revenue, retention and veterinary-unit economics; without those data, the acquisition thesis is a watch item rather than a catalyst.
• Monitor WOOF as a read-through short/watch candidate rather than a direct substitute trade. If premiumization pressure is category-wide, its service and discretionary exposure could create negative estimate revisions; avoid initiating until its customer-traffic and liquidity metrics confirm comparable demand softness.